Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice

Figure 1

Bufalin inhibits tumor growth but has no effect on nude mouse survival. (A) Tumor volumes of control (NS), low-dose bufalin-treated (BF1), high-dose bufalin-treated (BF2), and LY294002-treated (LY) groups by visual inspection. (B) Quantitation of tumor volumes in control (NS), low-dose bufalin-treated (BF1), high-dose bufalin-treated (BF2), and LY294002-treated (LY) groups. (C) Quantitation of tumor weights in control (NS), low-dose bufalin-treated (BF1), high-dose bufalin-treated (BF2), and LY294002-treated (LY) groups. (D) Tumor inhibition rates of control (NS), low-dose bufalin-treated (BF1), high-dose bufalin-treated (BF2), and LY294002-treated (LY) groups. (E) Nude mouse body weights of control (NS), low-dose bufalin-treated (BF1), high-dose bufalin-treated (BF2), and LY294002-treated (LY) groups. All data represent the mean ± SD (n = 6). *P < 0.05 vs. control (NS); †P < 0.01 vs. control (NS).

Back to article page